Skip to main content
. 2023 Sep 12;17:1231584. doi: 10.3389/fnins.2023.1231584

Table 1.

Participant details.

Paticipant Age Gender Exon Mutations
Controls
Control1 53 M
Control2 51 M
Control3 47 F
SPG7 patients
Patient1 62 M Exon 10 c.1449 + 1G > A
Exon 11 c.1529C > T
Patient2 52 M Exon 4 c.415C > T
Exon 7 c.941 T > A
Patient3 47 M Intron 16-Exon 17 chr16:g.89623293A > G, c.2182-2A > G
Exon 11 c.1529C > T

Age, gender and/or mutation details of the study participants.